Dyadic International Inc (NASDAQ:DYAI)
| 2.28 Delayed Data As of May 31 |  +0.05 / +2.24%Today’s Change | 1.12 Today|||52-Week Range 3.56 | +85.37% Year-to-Date |
| SECTOR Health Services | INDUSTRY Medical/Nursing Services | MARKET CAP $62.5M |
Company Description
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
Contact Information
Dyadic International, Inc. 140 Intracoastal Pointe Drive Jupiter Florida 33477-5094 |
Employees
Shareholders
| Individual stakeholders | 42.57% |
| Mutual fund holders | 3.66% |
| Other institutional | 11.81% |
Top Executives
| Mark A. Emalfarb | President, Chief Executive Officer & Director |
| Ping W. Rawson | Chief Financial Officer |
| Ronen Tchelet | Vice President-Research & Business Development |
| Joseph P. Hazelton | Chief Business Officer |
